| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. | PLoS One | 2011 | 1.16 |
| 2 | The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study. | Cancer Immunol Immunother | 2013 | 0.89 |
| 3 | Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma. | Cancer Immunol Immunother | 2015 | 0.77 |